Prescription Drug News and Research

RSS

Biden is right about $35 insulin cap but exaggerates prior costs for Medicare enrollees

The cost of insulin in the United States has risen considerably in recent years, with some estimates finding that Americans have paid around 10 times as much for the drug as people in other developed countries.

5 Apr 2024

Teva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicines

Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicine.

26 Mar 2024

Special drug-pricing program boosts prostate cancer treatment adherence

Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at other hospitals, according to a study from researchers at the University of Michigan's Rogel Cancer Center and Institute for Healthcare Policy and Innovation.

20 Mar 2024

Caffeine vs. creatine: The impact on cognitive and physical performances

The individual and combined effects of caffeine and creatine nitrate on cognitive and exercise performance.

11 Mar 2024

When it comes to ketamine, Meta’s posting policy is no party to decipher

People keep talking about ketamine. The drug has become a favorite of celebrities, billionaires, and ordinary patients, many of whom view it as a potential miracle drug for depression and other mental health conditions.

7 Mar 2024

Biden is right. The US generally pays double that of other countries for Rx drugs.

It's well documented that Americans pay high prices for health care. But do they pay double or more for prescriptions compared with the rest of the world? President Joe Biden said they did.

6 Mar 2024

Increased drug coverage restrictions in Medicare Part D raises concerns

Medicare Part D plans significantly increased restrictions on prescription drugs, excluding more compounds from coverage or subjecting more of them to review before patients could access the treatments, according to a new study from USC researchers.

4 Mar 2024

KFF Health News' 'What the Health?': Alabama’s IVF ruling still making waves

Reverberations from the Alabama Supreme Court's first-in-the-nation ruling that embryos are legally children continued this week, both in the states and in Washington.

29 Feb 2024

An Arm and a Leg: Wait, is Insulin cheaper now?

Pharmaceutical companies that manufacture insulin made headlines last year when they voluntarily agreed to provide discount cards that lower the monthly cost of insulin for many people to $35.

28 Feb 2024

Study: Most new prescription drugs sold first in the U.S.

Most new prescription drugs are sold first in the U.S. before they reach other nations, but ultimately important medications are sold across most wealthy nations within about a year of first sale, according to a new RAND report.

5 Feb 2024

New AI tool hunts down Medicare fraud in the "vast sea" of big data

Medicare is sporadically compromised by fraudulent insurance claims. These illicit activities often go undetected, allowing full-time criminals and unscrupulous health providers to exploit weaknesses in the system.

31 Jan 2024

KFF Health News' 'What the Health?': Health enters the presidential race

Based on the results of the first-in-the-nation primary in New Hampshire, it appears more likely than ever before that the 2024 presidential election will be a rerun of 2020: Joe Biden versus Donald Trump. And health is shaping up to be a key issue.

25 Jan 2024

CDC report highlights urgent need for guideline adherence in prescribing antifungal medications

The CDC's study on Medicare Part D beneficiaries reveals high prescription rates and costs for topical antifungal medications, emphasizing the need for proper prescribing guidelines amid rising antimicrobial-resistant fungal infections.

16 Jan 2024

Planning prompts show promise in improving prescribing safety

Physicians who are notified that a patient has died of a drug overdose are more judicious in issuing controlled substances if the notification includes a plan for what to do during subsequent patient visits, according to a study published today in Nature Communications.

13 Jan 2024

Ginseng's hidden gems: Rare ginsenosides emerge as potent players in the future of medicine

Review in the Journal of Advanced Research summarizes the properties, applications, and production of rare ginsenosides (RGs), highlighting their potential in treating various diseases including cancer and cardiovascular ailments.

8 Jan 2024

UK drug regulators failing to protect patients from harmful weight loss

UK organizations responsible for protecting the public from prescription-only drug adverts are putting patients at risk from the harms of weight loss drugs by not enforcing the law, reveals an investigation published by The BMJ today.

14 Dec 2023

Medicare Part D found to over-reimburse pharmacies for generic drugs

Medicare is the single largest provider of health insurance in the United States, serving 63.8 million senior citizens as of 2022.

5 Dec 2023

Study finds racial disparity in the utilization of crucial prostate cancer therapy

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.

1 Dec 2023

Uncle Sam wants you … to help stop insurers’ bogus Medicare Advantage sales tactics

After an unprecedented crackdown on misleading advertising claims by insurers selling private Medicare Advantage and drug plans, the Biden administration hopes to unleash a special weapon to make sure companies follow the new rules: you.

30 Nov 2023

Cannabis vaping linked to increased use of other substances, study finds

Short communication paper examines the link between cannabis vaping and the use of other substances, comparing cannabis vape users to non-vaping cannabis users. It reveals that cannabis vapers are more likely to use other substances like alcohol, tobacco, and illicit drugs, especially among younger demographics.

26 Nov 2023